SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007973
Filing Date
2019-08-12
Accepted
2019-08-12 16:03:39
Documents
75
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20190630x10q.htm 10-Q 1828484
2 EX-10.7 aplt-20190630ex1075899c7.htm EX-10.7 61930
3 EX-31.1 aplt-20190630ex311674021.htm EX-31.1 11582
4 EX-31.2 aplt-20190630ex312bc66c7.htm EX-31.2 11959
5 EX-32.1 aplt-20190630ex321382236.htm EX-32.1 10172
6 GRAPHIC aplt20190630ex1075899c7001.jpg GRAPHIC 22889
  Complete submission text file 0001558370-19-007973.txt   5956925

Data Files

Seq Description Document Type Size
7 EX-101.INS aplt-20190630.xml EX-101.INS 948532
8 EX-101.SCH aplt-20190630.xsd EX-101.SCH 55863
9 EX-101.CAL aplt-20190630_cal.xml EX-101.CAL 25912
10 EX-101.DEF aplt-20190630_def.xml EX-101.DEF 220652
11 EX-101.LAB aplt-20190630_lab.xml EX-101.LAB 423057
12 EX-101.PRE aplt-20190630_pre.xml EX-101.PRE 356026
Mailing Address 340 MADISON AVENUE 19TH FLOOR NEW YORK NY 10173
Business Address 340 MADISON AVENUE 19TH FLOOR NEW YORK NY 10173 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 191016456
SIC: 2834 Pharmaceutical Preparations